cognitive impairment

Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer’s Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study

Cerebrospinal Fluid Biomarkers Cerebrospinal fluid (CSF) serves as a crucial medium for examining biomarkers that can provide insights into neurological […]

Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer’s Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study Read Post »

Corrigendum to “Ginsenoside Rg1 alleviates cognitive impairment in vascular dementia by modulating Adcy1/Kdr-mediated cholinergic synapse and PI3K-AKT pathway” [Phytomedicine, 143 (2025) 156882]

Study Overview This research investigates the role of Ginsenoside Rg1, a principal bioactive compound derived from ginseng, in addressing cognitive

Corrigendum to “Ginsenoside Rg1 alleviates cognitive impairment in vascular dementia by modulating Adcy1/Kdr-mediated cholinergic synapse and PI3K-AKT pathway” [Phytomedicine, 143 (2025) 156882] Read Post »

Correction to “Interpreting the Hospital Anxiety and Depression Scale (HADS) for individuals with traumatic brain injury: Clinical correlates and empirical severity cutoffs” by Fox et al. (2026)

Study Overview The primary objective of the research conducted by Fox et al. (2026) was to enhance the understanding of

Correction to “Interpreting the Hospital Anxiety and Depression Scale (HADS) for individuals with traumatic brain injury: Clinical correlates and empirical severity cutoffs” by Fox et al. (2026) Read Post »

Correction to “Interpreting the Hospital Anxiety and Depression Scale (HADS) for individuals with traumatic brain injury: Clinical correlates and empirical severity cutoffs” by Fox et al. (2026)

Study Overview This study, conducted by Fox et al. (2026), addresses the significance of the Hospital Anxiety and Depression Scale

Correction to “Interpreting the Hospital Anxiety and Depression Scale (HADS) for individuals with traumatic brain injury: Clinical correlates and empirical severity cutoffs” by Fox et al. (2026) Read Post »

Scroll to Top